ReviewFrontiers in cardiovascular medicine2026

Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors.

Kausik Umanath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.